Israeli drug from COVID-19 showed high efficiency: now it is tested in the United States

In the United States, they started testing an Israeli drug for the first time, which is reported to be 19% effective in the treatment of even seriously ill patients with COVID-XNUMX. Writes about this "Observer".

Photo: Shutterstock

Seven Israeli patients at high risk of death due to respiratory as well as heart and kidney failure survived after taking this medicine.

The company Pluristem Therapeutics, which was engaged in the development of the drug, said that the active substance of the drug can suppress the excessive reaction of the infected immune system to the virus. Many patients with COVID-19 die due to too violent reactions to the infection of their own immune system. It blocks virus-infected alveoli in the lungs, which causes their hardening and inability to perform respiratory function.

The company uses the placenta to grow smart cells and programs them to secrete therapeutic proteins in the body of patients.

Yaki Yanai, CEO and president of the company, said that a study would soon take place that could allow the active use of the drug.

“Having received the green light from regulators, it will be possible to prepare a huge number of therapeutic drugs. We can make cells very quickly to treat thousands of people,” he said.

On the subject: Survey: 29% of Americans believe that the coronavirus vaccine exists, but it is hidden

The treatment consists of 15-milliliter doses of cells known as placental expanded cells, which are given as simple intramuscular injections, he said. Once in the body, the cells become like a “small factory producing therapeutic proteins.”

Yaki Yanai clarified: “Patients who are in serious condition and die are actually dying from a severe respiratory disease. What's actually happening is a very high level of inflammation, and at a certain point the patient's immune system will attack, mainly in the lungs."

Until now, Pluristem technology has been mainly used to treat people suffering from poor blood flow in the legs, but the company's scientists were able to quickly redesign cells for treating patients with coronavirus.

“We take cells from the placenta after full-term birth. We have been able to develop technology to expand cells to very large numbers in an environment that mimics the human body. This technology makes it possible to treat more than 20 thousand people using one placenta,” he explained.

As ForumDaily wrote earlier:

• Two French hospitals began testing a drug based on hemoglobin obtained from the blood of annelids. A drug will help patients suffering from respiratory complications with COVID-19.
• In Italy, announced positive result of treatment of patients with coronavirus the drug against rheumatoid arthritis "Tocilizumab" (Tocilizumab) manufactured by the pharmaceutical company Roche
• Researchers from France published a statement detailing how combination of antimalarial drugs and antibiotics can be an important weapon in the fight against coronavirus.
• In different states, the disease spreads at different rates. And for some reason, a coronavirus infection (at least at first glance) shows significantly less activity in countries, where children are necessarily vaccinated against tuberculosis using the BCG vaccine.
• According to new data based on patient observations, more than two-thirds are hard patients with COVID-19 improved after treatment with Remdesivir, an experimental drug developed by California-based Gilead Sciences Inc.
• Exist a number of drugsthat doctors around the world are trying to treat COVID-19

Read also on ForumDaily:

Survey: 29% of Americans believe that the coronavirus vaccine exists, but it is hidden

Three times as many: US expanded coronavirus symptoms list

Humidity and sunlight: what weather kills coronavirus fastest

Coronavirus hardly transmits across surfaces: important evidence from new studies

Do you want more important and interesting news about life in the USA and immigration to America? — support us donate! Also subscribe to our page Facebook. Select the “Priority in display” option and read us first. Also, don't forget to subscribe to our РєР ° РЅР ° Р »РІ Telegram  and Instagram- there is a lot of interesting things there. And join thousands of readers ForumDaily New York — there you will find a lot of interesting and positive information about life in the metropolis.